Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.

Source:http://linkedlifedata.com/resource/pubmed/id/20498254

J. Pharmacol. Exp. Ther. 2010 Sep 1 334 3 682-92

Download in:

View as

Triples

General Info

PMID
20498254